Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Investor Presentation | Value Research

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Investor Presentation

Further to our letter dated September 6 2022 informing about the participation in the Kotak Institutional Equity Healthcare Forum 2022 on September 8 2022 we inform you that the presentation updated in the following weblink of the Company will be used during the interaction with the investors.https://www.aurobindo.com/wp-content/uploads/2022/09/Aurobindo-Pharma_Investor-Presentation_INR_Sep-22.pdfNo unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.

Click here to view PDF


Other Categories